These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 1470277

  • 1. Tubeless tests of exocrine pancreatic function in patients with cystic fibrosis.
    Lamers CB.
    Neth J Med; 1992 Oct; 41(3-4):101-4. PubMed ID: 1470277
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of tests of exocrine and endocrine pancreatic function in older patients with cystic fibrosis.
    Lamers CB, Jansen JB, Hafkenscheid JC, Jongerius CM.
    Pancreas; 1990 Oct; 5(1):65-9. PubMed ID: 1688391
    [Abstract] [Full Text] [Related]

  • 3. Quantitative assessment of pancreatic function by magnetic resonance in cystic fibrosis.
    Heijerman HG, Tjon a Tham RT, Bakker W, Falke TH, Lamers CB.
    Neth J Med; 1993 Aug; 43(1-2):59-63. PubMed ID: 8232695
    [Abstract] [Full Text] [Related]

  • 4. Comparative diagnostic accuracy of four tubeless pancreatic function tests in chronic pancreatitis.
    Ammann RW, Bühler H, Pei P.
    Scand J Gastroenterol; 1982 Nov; 17(8):997-1002. PubMed ID: 6984771
    [Abstract] [Full Text] [Related]

  • 5. Pancreolauryl test for pancreatic exocrine insufficiency.
    Ventrucci M, Gullo L, Daniele C, Priori P, Labò G.
    Am J Gastroenterol; 1983 Dec; 78(12):806-9. PubMed ID: 6606355
    [Abstract] [Full Text] [Related]

  • 6. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K, Weren M, Proesmans M, Kerem E.
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum immunoreactive pancreatic lipase and cationic trypsinogen for the assessment of exocrine pancreatic function in older patients with cystic fibrosis.
    Cleghorn G, Benjamin L, Corey M, Forstner G, Dati F, Durie P.
    Pediatrics; 1986 Mar; 77(3):301-6. PubMed ID: 3951910
    [Abstract] [Full Text] [Related]

  • 9. Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.
    Dorlöchter L, Aksnes L, Fluge G.
    Eur J Nutr; 2002 Aug; 41(4):148-52. PubMed ID: 12242582
    [Abstract] [Full Text] [Related]

  • 10. Bentiromide test for assessing pancreatic dysfunction using analysis of para-aminobenzoic acid in plasma and urine. Studies in cystic fibrosis and Shwachman's syndrome.
    Weizman Z, Forstner GG, Gaskin KJ, Kopelman H, Wong S, Durie PR.
    Gastroenterology; 1985 Sep; 89(3):596-604. PubMed ID: 3874804
    [Abstract] [Full Text] [Related]

  • 11. [The diagnostic validity of non-invasive pancreatic function tests--a meta-analysis].
    Siegmund E, Löhr JM, Schuff-Werner P.
    Z Gastroenterol; 2004 Oct; 42(10):1117-28. PubMed ID: 15508057
    [Abstract] [Full Text] [Related]

  • 12. [Value of isoamylases in the diagnosis of exocrine pancreatic insufficiency in childhood].
    Morgenstern T, Niessen KH, Teufel M.
    Monatsschr Kinderheilkd; 1984 Sep; 132(9):661-5. PubMed ID: 6208482
    [Abstract] [Full Text] [Related]

  • 13. [Modified ALTAB test in the diagnosis of exocrine pancreatic insufficiency].
    Rageh W, Klugmann HJ, Schiedewitz W, Pohl A.
    Dtsch Z Verdau Stoffwechselkr; 1985 Sep; 45(6):307-16. PubMed ID: 3879216
    [Abstract] [Full Text] [Related]

  • 14. [Examination of pancreatic function in children with special reference to the PABA-test (author's transl)].
    Dockter G, Sitzmann FC.
    Monatsschr Kinderheilkd; 1980 Dec; 128(12):732-8. PubMed ID: 6161302
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
    Stern RC, Eisenberg JD, Wagener JS, Ahrens R, Rock M, doPico G, Orenstein DM.
    Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
    [Abstract] [Full Text] [Related]

  • 16. [Improvement in the specificity of the PABA test (PFT) by combined PABA peptide/D-xylose administration and serum kinetic measurement?].
    Bornschein W.
    Z Gastroenterol; 1985 May; 23(5):247-56. PubMed ID: 3878635
    [Abstract] [Full Text] [Related]

  • 17. [Serum paraaminobenzoic acid following the use of N-benzoyl-L-tyrosyl-paraaminobenzoic acid in the diagnosis of pancreatic insufficiency].
    Wolf C, Ehrig C, Brunner H.
    Schweiz Med Wochenschr; 1981 Mar 07; 111(10):343-7. PubMed ID: 6971491
    [Abstract] [Full Text] [Related]

  • 18. [The diagnostic value of serum PABA determination in pancreatic disease and in relation to anticholinergic medication].
    von Kleist D, Rössler W, Janisch HD, Hampel KE.
    Gastroenterol J; 1989 Mar 07; 49(3):108-12. PubMed ID: 2698170
    [Abstract] [Full Text] [Related]

  • 19. How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease?
    Beharry S, Ellis L, Corey M, Marcon M, Durie P.
    J Pediatr; 2002 Jul 07; 141(1):84-90. PubMed ID: 12091856
    [Abstract] [Full Text] [Related]

  • 20. Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy.
    Konstan MW, Stern RC, Trout JR, Sherman JM, Eigen H, Wagener JS, Duggan C, Wohl ME, Colin P.
    Aliment Pharmacol Ther; 2004 Dec 07; 20(11-12):1365-71. PubMed ID: 15606399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.